Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Recent & Breaking News (TSX:SVA)

Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences

GlobeNewswire March 2, 2023

Sernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total Thyroidectomy

GlobeNewswire January 30, 2023

Sernova (TSX:SVA) progresses on Cell Pouch device project

Caroline Egan  January 10, 2023

Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes

GlobeNewswire January 10, 2023

Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

GlobeNewswire December 6, 2022

Sernova's (TSX:SVA) implants the first two patients with Cell Pouch in its clinical trial

Brieanna McCutcheon  November 17, 2022

Sernova Announces First Two Patients Implanted with Cell Pouch(TM) in the Second Cohort of its US Phase 1/2 Clinical Trial for Type 1 Diabetes

GlobeNewswire November 17, 2022

Sernova to Participate in the Stifel Healthcare Conference

GlobeNewswire November 4, 2022

Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System(TM) for Type 1 Diabetes

GlobeNewswire November 3, 2022

Sernova Corp. Announces Change of Auditor

TheNewsWire October 24, 2022

Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference

GlobeNewswire September 28, 2022

Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022

GlobeNewswire September 22, 2022

Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium

GlobeNewswire September 8, 2022

Sernova (TSX:SVA) appoints Daniel Mahony, Ph.D. to its Board of Directors

Shoran Devi September 7, 2022

Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors

GlobeNewswire September 7, 2022

Sernova (TSX:SVA) completes final tranche of $6.77M financing

Caroline Egan  September 1, 2022

Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share

GlobeNewswire September 1, 2022

Sernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.

GlobeNewswire August 30, 2022

Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June

GlobeNewswire June 15, 2022

Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System(TM) at American Diabetes Association 82nd Scientific Sessions 2022

GlobeNewswire June 6, 2022